The original characterization by the Sikiri group framed the larger parent protein in human gastric juice as a protective factor for the gastrointestinal mucosa, with body protection compound (BPC) referring to that broader protective role
Pro-angiogenic BPC157 associated with VEGFR2 activation and up-regulation
Early animal studies suggest it may help repair damaged tissue throughout the body
Rotator cuff injuries, shoulder impingement, bicep tendon issues, and general shoulder inflammation appear particularly responsive to BPC-157 protocols
11.8% at 2.4 mg vs 2.3% placebo (68 wk) 9.5% to 20.1% across dose arms vs 0.4% placebo (48 wk) Tolerability signal Mostly gastrointestinal nausea, vomiting, diarrhoea, constipation
They promised cheap access to compounded versions of the medications Ozempic (which includes the active ingredient semaglutide) and Mounjaro in the middle of an unprecedented global shortages